Search

Nathaniel Landau Phones & Addresses

  • 430 E 63Rd St APT 8C, New York, NY 10065 (212) 759-2561
  • 10010 Torrey Pines Rd, La Jolla, CA 92037
  • 4579 Mercurio St, San Diego, CA 92130
  • Somerville, MA
  • Teaneck, NJ
  • 430 E 63Rd St APT 8C, New York, NY 10065

Work

Position: Sales Occupations

Resumes

Resumes

Nathaniel Landau Photo 1

Chief Digital Officer

View page
Location:
69 Downing St, Brooklyn, NY 11238
Industry:
Internet
Work:
Food Republic since Sep 2010
General Manager, Managing Director

Zerve.com Nov 2009 - Sep 2010
VP, Product Development

Imaginova Feb 2007 - Jun 2009
VP, General Manager - Consumer Media

Imaginova Feb 2007 - Oct 2008
Vice President of Internet Operations

Arch Insurance Group Jul 2003 - Feb 2007
Director of Internet Products, Lead Information Architect
Education:
Vassar College 1992 - 1996
B.A., Sociology and History
Skills:
Product Management
Seo
Management
Digital Strategy
Marketing Strategy
Business Strategy
Web Analytics
Digital Media
Content Strategy
Business Development
Start Ups
Strategy
E Commerce
Entrepreneurship
Usability
Fundraising
Digital Marketing
Relationship Marketing
Analytics
Sales Management
Software Engineering
Mobile Devices
Web Content
New Media
Advertising
User Experience
Early Stage Startups
Social Media
Online Advertising
Strategic Partnerships
Mobile Applications
Leadership
Marketing
Product Development
Online Marketing
Business Analysis
Cross Functional Team Leadership
Strategic Planning
Data Analysis
Business Process Improvement
Project Management
Program Management
Team Building
Team Management
Vendor Management
Business Planning
Customer Acquisition
Customer Experience
Nathaniel Landau Photo 2

Professor

View page
Location:
New York, NY
Industry:
Research
Work:
Nyu School of Medicine
Professor
Nathaniel Landau Photo 3

Nathaniel Landau

View page
Location:
New York, NY
Nathaniel Landau Photo 4

General Manager At Food Republic

View page
Position:
General Manager, Managing Director at Food Republic
Location:
Greater New York City Area
Industry:
Internet
Work:
Food Republic since Sep 2010
General Manager, Managing Director

Zerve.com Nov 2009 - Sep 2010
VP, Product Development

Imaginova Feb 2007 - Jun 2009
VP, General Manager - Consumer Media

Imaginova Feb 2007 - Oct 2008
Vice President of Internet Operations

Arch Insurance Group Jul 2003 - Feb 2007
Director of Internet Products, Lead Information Architect
Education:
Vassar College 1992 - 1996
B.A., Sociology and History
Skills:
Fundraising
Product Management
Marketing Strategy
Business Strategy
Digital Strategy
Content Strategy
SEO
Sales Management
Entrepreneurship
Early-stage Startups
Management
Web Analytics
Usability
Business Development
Relationship Marketing
Usability
Software Engineering
Nathaniel Landau Photo 5

Nathaniel Landau

View page
Location:
Greater New York City Area
Industry:
Internet

Business Records

Name / Title
Company / Classification
Phones & Addresses
Nathaniel Landau
Vice President Operations
IMAGINOVA CORP
Marketing Consulting Svcs
470 Park Ave S FL 9S, New York, NY 10016
(212) 703-5800

Publications

Us Patents

Methods Of Identifying G-Couple Receptors Associated With Macrophage-Trophic Hiv, And Diagnostic And Therapeutic Uses Thereof

View page
US Patent:
7129055, Oct 31, 2006
Filed:
Dec 11, 2000
Appl. No.:
09/734221
Inventors:
Dan R. Littman - New York NY, US
Hongkui Deng - Worcester MA, US
Wilfried Ellmeier - New York NY, US
Nathaniel R. Landau - New York NY, US
Rong Liu - New York NY, US
Assignee:
New York University - New York NY
International Classification:
C01N 33/53
C01N 33/533
C12N 15/00
C12N 15/48
C12N 15/07
C12N 15/09
C12N 5/28
C07K 16/28
US Classification:
435 72, 435 721, 435 724, 435 78, 435 793, 435325, 435 691, 435440, 53038822
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the β-chemokines RANTES, MIP-1α, and MIP-1β.

Alpha-Complementation Viral Fusion Assay

View page
US Patent:
7312031, Dec 25, 2007
Filed:
Dec 4, 2003
Appl. No.:
10/729069
Inventors:
Carsten Muenk - Frankfurt, DE
Anne Holland - San Diego CA, US
Nathaniel Landau - San Diego CA, US
Assignee:
The Salk Institute for Biological Studies - San Diego CA
International Classification:
C12Q 1/70
G01N 33/567
US Classification:
435 5, 435 721
Abstract:
The present invention relates to the use of an alpha complementation assay as a quick, effective, and safe method for the detection of cell fusion mediated by viral proteins. Additionally, the method disclosed herein permits the identification of inhibitors of cell fusion using an alpha complementation assay.

Lentiviral Vectors And Methods Of Use Thereof

View page
US Patent:
20130183334, Jul 18, 2013
Filed:
Jan 17, 2013
Appl. No.:
13/743877
Inventors:
Nathaniel R. Landau - New York NY, US
Nicole Sunseri - New York NY, US
Thomas D. Norton - New York NY, US
International Classification:
A61K 39/21
US Classification:
4241991, 4353201, 4352351
Abstract:
The compositions and methods described herein relate to lentiviral vectors that can be used to generate virions/viruses that exhibit enhanced infectivity with respect to monocyte-derived macrophages (MDM) and dendritic cells (MDDC). Such compositions and methods further relate to production of virions/viruses that can be used as components of vaccines that effectively stimulate innate immune responses. In a particular embodiment, compositions and methods described herein relate to production of virions/viruses that can be used as components of human immunodeficiency-1 (HIV-1) vaccines administered to stimulate innate immune responses to HIV-1.

Methods Of Identifying G-Coupled Receptors Associated With Macrophage-Trophic Hiv, And Diagnostic And Therapeutic Uses Thereof

View page
US Patent:
62585274, Jul 10, 2001
Filed:
May 21, 1997
Appl. No.:
8/861105
Inventors:
Dan R. Littman - New York NY
Hongkui Deng - Worcester MA
Wilfried Ellmeier - New York NY
Nathaniel R. Landau - New York NY
Rong Liu - New York NY
Assignee:
The Aaron Diamond Aids Research Center - New York NY
New York University - New York NY
International Classification:
C12Q 170
G01N 33567
C12N 510
US Classification:
435 5
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the. beta. -chemokines RANTES, MIP-1. alpha. , and MIP-1. beta.

Hiv Coreceptor Mutants

View page
US Patent:
60571020, May 2, 2000
Filed:
Aug 8, 1997
Appl. No.:
8/907468
Inventors:
Nathaniel R. Landau - New York NY
Richard A. Koup - Southlake TX
Rong Liu - New York NY
William Paxton - Amsterdam, NL
Assignee:
The Aaron Diamond Aids Research Center - New York NY
International Classification:
C12Q 168
C12Q 170
US Classification:
435 6
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the. beta. -chemokines RANTES, MIP-1. alpha. , and MIP-1. beta. It has also been found that individuals who are homozygous for a mutation of the CKR-5 receptor are resistent to HIV infection; in vitro infection requires a 1000-fold higher dose of HIV than normal cells. The mutation results in complete suppression of CKR-5 expression.

G-Coupled Receptors Associated With Macrophage-Trophic Hiv, And Diagnostic And Therapeutic Uses Thereof

View page
US Patent:
59393203, Aug 17, 1999
Filed:
Jun 19, 1996
Appl. No.:
8/666020
Inventors:
Dan R. Littman - New York NY
Hongkui Deng - New York NY
Wilfried Ellmeier - New York NY
Nathaniel R. Landau - New York NY
Rong Liu - New York NY
Assignee:
New York University - New York NY
The Aaron Diamond Aids Research Center - New York NY
International Classification:
C12N 506
C12N 510
C12N 508
US Classification:
435325
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the. beta. -chemokines RANTES, MIP-1. alpha. , and MIP-1. beta.
Nathaniel R Landau from New York, NY, age ~70 Get Report